International Pharmaceutical Aerosol Consortium
🤖
AI Overview
With $0 in lobbying spend across 32 quarterly filings, International Pharmaceutical Aerosol Consortium is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2025.
$0
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Environment
- •S. 2657, Advanced Geothermal Innovation Leadership Act of 2019.
- •Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic.
- •Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic; reclamation
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.